Ardian unitranche injection for biotech buyout

The direct lender put up €92 million in blended financing to back the biotechnology investment.

ByRachel McGovern

17 December 2014•1 min read

[data-article-body-skeleton]{display:none!important}

JavaScript is required to read this article. Please enable it in your browser and reload the page.

Ardian unitranche injection for biotech buyout